Manhattan Associates Stock Price, News & Analysis (NASDAQ:MANH)

Manhattan Associates trades on the NASDAQ under the ticker symbol "MANH."

Manhattan Associates announced that its Board of Directors has initiated a stock buyback plan on Wednesday, February 7th 2018, which authorizes the company to repurchase $50,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are often an indication that the company's leadership believes its shares are undervalued.

Manhattan Associates, Inc. (NASDAQ:MANH) released its earnings results on Tuesday, July, 23rd. The software maker reported $0.42 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.25 by $0.17. The software maker had revenue of $154.30 million for the quarter, compared to analyst estimates of $146 million. Manhattan Associates had a net margin of 16.33% and a return on equity of 66.00%. The firm's revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.47 EPS. View Manhattan Associates' Earnings History.

Manhattan Associates is scheduled to release their next quarterly earnings announcement on Tuesday, October 22nd 2019. View Earnings Estimates for Manhattan Associates.

Manhattan Associates will be holding an earnings conference call on Tuesday, October 22nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Manhattan Associates issued an update on its FY19 earnings guidance on Tuesday, July, 23rd. The company provided EPS guidance of $1.46-1.50 for the period, compared to the Thomson Reuters consensus estimate of $1.44. The company issued revenue guidance of $598-604 million, compared to the consensus revenue estimate of $588.50 million.

3 brokers have issued 1 year target prices for Manhattan Associates' stock. Their forecasts range from $90.00 to $100.00. On average, they anticipate Manhattan Associates' share price to reach $94.00 in the next year. This suggests a possible upside of 14.2% from the stock's current price. View Analyst Price Targets for Manhattan Associates.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Manhattan Associates in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Manhattan Associates.

Media stories about MANH stock have trended very negative this week, InfoTrie Sentiment reports. The research firm scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Manhattan Associates earned a daily sentiment score of -3.2 on InfoTrie's scale. They also assigned headlines about the software maker a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Manhattan Associates.

Some companies that are related to Manhattan Associates include Synopsys (SNPS), ANSYS (ANSS), Cadence Design Systems (CDNS), Splunk (SPLK), Check Point Software Technologies (CHKP), Twilio (TWLO), Tableau Software (DATA), Atlassian (TEAM), Symantec (SYMC), TAKE-TWO INTERACTIVE SOFTWARE (TTWO), Okta (OKTA), Paycom Software (PAYC), Citrix Systems (CTXS), SS&C Technologies (SSNC) and Crowdstrike (CRWD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Manhattan Associates investors own include Aralez Pharmaceuticals (ARLZ), Visa (V), Gilead Sciences (GILD), Netflix (NFLX), Starbucks (SBUX), Skyworks Solutions (SWKS), Nike (NKE), Broadcom (AVGO), Celgene (CELG) and Cisco Systems (CSCO).

Manhattan Associates' stock is owned by a variety of of retail and institutional investors. Top institutional investors include West Coast Financial LLC (0.07%), Denali Advisors LLC (0.05%), Pacer Advisors Inc. (0.04%), Capital Insight Partners LLC (0.03%), Douglas Lane & Associates LLC (0.03%) and CIBC Private Wealth Group LLC (0.03%). Company insiders that own Manhattan Associates stock include Bruce Richards, Dennis B Story, Eddie Capel, Edmond Eger, John J Huntz Jr and Robert G Howell. View Institutional Ownership Trends for Manhattan Associates.

MANH stock was sold by a variety of institutional investors in the last quarter, including Denali Advisors LLC, Douglas Lane & Associates LLC, West Coast Financial LLC, CIBC Private Wealth Group LLC, Pacer Advisors Inc., Crossmark Global Holdings Inc. and Capital Insight Partners LLC. Company insiders that have sold Manhattan Associates company stock in the last year include Bruce Richards, Dennis B Story, Eddie Capel, John J Huntz Jr and Robert G Howell. View Insider Buying and Selling for Manhattan Associates.

MANH stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue and Fox Run Management L.L.C.. View Insider Buying and Selling for Manhattan Associates.

Shares of MANH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MANH stock can currently be purchased for approximately $82.33.

Manhattan Associates has a market capitalization of $5.30 billion and generates $559.16 million in revenue each year. The software maker earns $104.69 million in net income (profit) each year or $1.58 on an earnings per share basis. Manhattan Associates employs 3,000 workers across the globe.View Additional Information About Manhattan Associates.

The official website for Manhattan Associates is http://www.manh.com/.

Manhattan Associates' mailing address is 2300 WINDY RIDGE PARKWAY TENTH FLOOR, ATLANTA GA, 30339. The software maker can be reached via phone at 770-955-7070 or via email at [email protected]